Osteoprotegerin as a Marker of Atherosclerosis in Diabetic Patients
Open Access
- 17 January 2013
- journal article
- review article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2013, 1-6
- https://doi.org/10.1155/2013/182060
Abstract
Atherosclerosis is the principal cause of cardiovascular disease (CVD) and has many risk factors, among which is diabetes. Osteoprotegerin (OPG) is a soluble glycoprotein, involved in bone metabolism. OPG is also found in other tissues, and studies have shown that it is expressed in vascular smooth muscle cells. OPG has been implicated in various inflammations and also has been linked to diabetes mellitus. Increased serum OPG levels were found in patients with diabetes and poor glycemic control. Furthermore, prepubertal children with type 1 diabetes have significantly increased OPG levels. Receptor activator of nuclear factor kappa-B ligand (RANKL) is not found in the vasculature in normal conditions, but may appear in calcifying areas. OPG and RANKL are important regulators of mineral metabolism in both bone and vascular tissues. Few data are available on the relationship between plasma OPG/RANKL levels and endothelial dysfunction as assessed using noninvasive methods like ultrasound indexes, neither in the general population nor, more specifically, in diabetic patients. The aim of our review study was to investigate, based on the existing data, these interrelationships in order to identify a means of predicting, via noninvasive methods, later development of endothelial dysfunction and vascular complications in diabetic patients.Keywords
This publication has 71 references indexed in Scilit:
- Previous Gestational Diabetes Mellitus and Markers of Cardiovascular RiskInternational Journal of Endocrinology, 2012
- Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitusCardiovascular Diabetology, 2011
- Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectorisAtherosclerosis, 2010
- Biomarkers of the Osteoprotegerin PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility studyCardiovascular Diabetology, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisThe New England Journal of Medicine, 2009
- Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetesAtherosclerosis, 2008
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in
ldlr
(−/−)
MiceCirculation, 2008
- Skeletal involvement in patients with diabetes mellitusDiabetes/Metabolism Research and Reviews, 2004
- Alterations in bone characteristics associated with glycemic control in adolescents with type 1 diabetes mellitusThe Journal of Pediatrics, 2004